Company · CIK 2007191
Telix Pharmaceuticals Ltd
| CIK | 2007191 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | C3 |
| Business address | Australia |
| Listed | TLX (Nasdaq), TLPPF (OTC) |
| First annual or quarterly report | 2025-02-24 |
Offerings
1 registration| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-279471 | 2024-05-17 | 2024-06-14 | 3 |
Filings
7| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2024-11-12 | EFFECTDeclared effective | 333-282705 | 9999999995-24-003460 |
| 2024-09-13 | DRSDraft made public | 377-07439 | 0001140361-24-040995 |
| 2024-06-14 | RWWithdrawn | 333-279808 | 0001140361-24-030136 |
| 2024-06-14 | RWWithdrawn | 333-279471 | 0001140361-24-030120 |
| 2024-06-05 | F-1/AAmendment | 333-279471 | 0001140361-24-028932 |
| 2024-05-17 | F-1Registration filed | 333-279471 | 0001140361-24-026584 |
| 2024-01-25 | DRSDraft made public | 377-07070 | 0001140361-24-003917 |